Outcomes and toxicities for the treatment of stage IVB cervical cancer.

被引：0
|
作者：
Hwang, J. H.
Lim, M. C.
Seo, S.
Kang, S.
Park, S.
Kim, J.
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Natl Canc Ctr, Koyang, South Korea
[3] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15586
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Metastatic site-specific prognosis of women with stage IVB cervical cancer
    Joh, Sarah
    Khetan, Varun
    Jooya, Neda
    Violette, Caroline
    Cahoon, Sigita
    Klar, Maximilian
    Matsuo, Koji
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S177 - S177
  • [32] Survival outcomes of neoadjuvant therapy for the treatment of stage IVB endometrial adenocarcinoma
    Elnaggar, Adam C.
    Neff, Robert
    Palettas, Marilly
    Pollock, Samara
    Ulm, Michael
    Gold, Joann
    Zhang, Naixin
    Tillmanns, Todd D.
    Cohn, David
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (04) : 50 - 57
  • [33] Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: a report of 7 cases and a review of the literature
    Mabuchi, Seiji
    Morishige, Kenichirou
    Enomoto, Takayuki
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2010, 21 (02) : 93 - 96
  • [34] Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis
    Kim, Hee Seung
    Kim, Taehun
    Lee, Eung Seok
    Kim, Hak Jae
    Chung, Hyun Hoon
    Kim, Jae Wean
    Song, Yong Sang
    Park, Noh Hyun
    CANCER RESEARCH AND TREATMENT, 2013, 45 (03): : 193 - 201
  • [35] Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis
    Li, Haoran
    Yang, Yufei
    Zhou, Hongyu
    Li, Fei
    Li, Mengjiao
    Chen, Lihua
    Wu, Xiaohua
    Chen, Xi
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1217 - +
  • [36] Stage IVA cervical cancer: outcomes of disease related complications and treatment
    Khulpateea, Beman Roy
    Paulson, Annette
    Carlson, Matthew
    Miller, David Scott
    Lea, Jayanthi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (04) : 518 - 523
  • [37] EXAMINING THE EFFECTS THAT A WOMAN'S AGE, HISTOLOGICAL SUBTYPE AND FIGO STAGE HAS ON THE TREATMENT STRATEGIES AND SURVIVAL OUTCOMES IN CERVICAL CANCER.
    Garry, N.
    Corbett, G.
    Thompson, C.
    Abu Saadeh, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 275 - 275
  • [38] Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy
    Ittiamornlert, Pornprom
    Ruengkhachorn, Irene
    BMC CANCER, 2019, 19 (1)
  • [39] Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study
    Jalloul, Randa J.
    Sharma, Shelly
    Tung, Celestine S.
    O'Donnell, Barrett
    Ludwig, Michelle
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (05) : 1003 - 1012
  • [40] Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy
    Pornprom Ittiamornlert
    Irene Ruengkhachorn
    BMC Cancer, 19
12345